Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study

Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

(2015) Karina Berg et al.   OPHTHALMOLOGY

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

(2014) Frank G Holz et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels

(2014) Zsolt Ablonczy et al.   FASEB JOURNAL

Why AMD is a disease of ageing and not of development: mechanisms and insights

(2014) Kaushal Sharma et al.   Frontiers in Aging Neuroscience

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis

(2014) Wan Ling Wong et al.   Lancet Global Health

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

(2013) Usha Chakravarthy et al.   LANCET

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

(2013) Brandon G. Busbee et al.   OPHTHALMOLOGY

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

(2012) Daniel F. Martin et al.   OPHTHALMOLOGY

ANATOMICAL MEASURES AS PREDICTORS OF VISUAL OUTCOMES IN RANIBIZUMAB-TREATED EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

(2012) David M. Brown et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration

(2012) Seenu M. Hariprasad et al.   Journal of Ophthalmology

Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study

(2010) Ursula Schmidt-Erfurth et al.   OPHTHALMOLOGY

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

(2009) David S. Boyer et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY